September 2025

Monthly Archives

Latest stories

More stories

  • Landmark Lung Cancer Studies Set to Alter Standard of Care Moffitt

    Lung Cancer Treatment Advancements Lung cancer remains one of the most fatal cancers worldwide. According to the American Cancer Society, lung cancer is the second most common cancer in both men and women, accounting for about 13% of all new cancer diagnoses. Several thousand new cases are diagnosed each year. However, new research presented at […] More

  • Unraveling the Impact of Tumor Microenvironment on DLBCL Prognosis and Treatment

    Understanding the Tumor Microenvironment in Diffuse Large B-Cell Lymphoma (DLBCL) Introduction Diffuse large B-cell lymphoma (DLBCL) is a complex disease, both in terms of its genetic makeup and the role of the tumor microenvironment (TME) in its development and progression. Research into these aspects of DLBCL has shown great promise in terms of developing more […] More

  • Genmab’s Innovative Therapies to Revolutionize Lymphoma Treatment Landscape

    Genmab’s Promising Clinical Data and Strong Pipeline Position Them as a Leader in Oncology Background on Genmab A/S Genmab A/S is a global biotech company dedicated to developing unique antibody therapeutics to treat cancer. Their monoclonal antibody products, DARZALEX and Arzerra, are currently used to treat patients with multiple myeloma and chronic lymphocytic leukemia, respectively. […] More

  • Digital cancer care startup lays off staff

    Virtual Cancer Care Startup Jasper Health Lays Off Staff Virtual cancer care startup Jasper Health has laid off staff, as reported by TechCrunch. The company reportedly had around 48 employees before making cuts that may have affected up to half of its workforce, according to a May 31 article. Jasper Health’s Offering Jasper Health offers […] More

  • The Ketamine Boom and Matthew Perry: Expensive, Dangerous, and En Vogue

    The Risks and Growing Use of Ketamine: A Look into Ketamine Clinics, Black Market, and Off-Label Use Ketamine, a dissociative anesthetic also known as “Special K” or “Super Acid,” has been the subject of growing concern as its use is on the rise. Although it has proven effective in treating certain medical conditions, including depression […] More

  • Janet Ewing Obituary Spring City PA The Mercury

    Janet M. Ewing: A Life Remembered Janet M. Ewing, a longtime resident of Spring City, passed away on Tuesday at Seasons Hospice in Phoenixville Hospital. She was 79 and had been preceded in death by her husband, Irvin Ewing. Janet was born in Spring City to Samuel Jefferson “Jeff” and Wilhelmina (Slifer) Slaughter. She had […] More

  • Molecular Switch Linked to Lineage Plasticity Therapy Resistance

    New Genetic Process Discovered to Potentially Treat Advanced Prostate Cancer A study from the UT Southwestern Medical Center has discovered two genes that play a critical role in shaping prostate cancer cells and their response to treatments. The findings, published in Cancer Discovery, provide crucial insights into how cancer cells adapt to current standard-of-care treatments […] More

  • Make-A-Wish Grants Polaris RZR to PHS Grad Odessa American

    Make-A-Wish and Odessa Family PowerSports Grant Local Teen’s Wish for Off-Road Vehicle Introduction Robert Galindo, a local teen diagnosed with Hodgkin’s Lymphoma in 2019, had his wish granted for an off-road vehicle by Make-A-Wish and Odessa Family PowerSports. The $10,000 donation from Odessa Family PowerSports to Make-A-Wish will help fund wishes for other local children […] More

  • Norwalk Hospital Launches Promising Cancer Trials with the Goal of Curing Patients

    The Benefits of Alternative Medicines for Healthcare Alternative medicines have been around for centuries, but they are only now becoming more widely accepted in the healthcare industry. These natural remedies can provide relief for a wide range of conditions, without the side effects that often come with prescription drugs. In this article, we will explore […] More

  • Lenvatinib Combo Enhances Clinical Benefit for Clear Cell RCC Subgroups

    Combination Therapy with Lenvatinib and Pembrolizumab Improves Clinical Benefits in Clear Cell RCC Patients: Biomarker Analysis from CLEAR Trial The results of the CLEAR trial, presented at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting, showed that combining lenvatinib (Lenvima) and pembrolizumab (Keytruda) was more effective in treating advanced clear cell renal cell […] More

  • Alligator Delivers Promising Pancreatic Cancer Drug Results at ASCO 2024

    Alligator’s Mitazalimab Shows Promise in Pancreatic Cancer Treatment Introduction Alligator Bioscience, a Sweden-based biotech company, recently presented promising results from its Phase II readout of mitazalimab, a monoclonal antibody, in combination with mFOLFIRINOX chemotherapy for the treatment of pancreatic cancer. The data was published in the Lancet Oncology on June 3, 2024, and the study […] More

Load More
Congratulations. You've reached the end of the internet.